🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
JW Pharmaceutical Corporation (KRX:001060)
South Korea flag South Korea · Delayed Price · Currency is KRW
23,550
+50 (0.21%)
Nov 20, 2026, 1:40 PM KST

JW Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
538,041584,933561,695828,523419,688505,678
Market Cap Growth
-4.80%4.14%-32.20%97.41%-17.00%-32.85%
Enterprise Value
507,707571,085600,784959,912491,395649,827
Last Close Price
23500.0024967.9023499.2034154.1717093.9720225.75

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
5.7110.199.1122.3913.16-
Forward PE
-6.186.5014.3410.4026.79
PS Ratio
0.650.750.781.110.610.83
PB Ratio
1.311.581.713.121.862.68
P/TBV Ratio
1.351.641.763.291.842.68
P/FCF Ratio
4.376.917.9013.848.9647.45
P/OCF Ratio
3.996.077.089.517.3927.90
PEG Ratio
-0.170.17---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
0.620.740.841.280.721.07
EV/EBITDA Ratio
3.915.365.908.056.3613.84
EV/EBIT Ratio
4.606.507.269.938.1221.07
EV/FCF Ratio
4.126.758.4516.0310.4960.98

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.180.150.280.640.931.30
Debt / EBITDA Ratio
0.560.510.901.432.715.22
Debt / FCF Ratio
0.580.651.292.844.4723.00
Net Debt / Equity Ratio
-0.07-0.020.180.290.270.95
Net Debt / EBITDA Ratio
-0.24-0.060.580.640.773.82
Net Debt / FCF Ratio
-0.25-0.080.831.271.2816.84
Asset Turnover
1.311.281.151.181.091.03
Inventory Turnover
3.743.753.643.793.703.65
Quick Ratio
1.000.860.820.900.800.79
Current Ratio
1.561.421.471.321.121.30
Return on Equity (ROE)
27.63%17.60%21.87%15.65%14.41%-0.73%
Return on Assets (ROA)
15.09%9.49%9.87%5.81%5.06%-0.16%
Return on Invested Capital (ROIC)
25.28%16.20%17.88%21.60%12.18%-0.62%
Return on Capital Employed (ROCE)
24.50%22.20%20.90%27.00%24.40%8.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
17.50%10.52%11.58%4.47%7.60%-0.19%
FCF Yield
22.87%14.47%12.65%7.23%11.16%2.11%
Dividend Yield
2.76%2.54%----
Payout Ratio
15.51%17.99%14.86%23.82%23.05%-
Buyback Yield / Dilution
1.42%1.40%2.01%-2.49%-0.07%0.05%
Total Shareholder Return
4.19%3.95%2.01%-2.49%-0.07%0.05%